Details for New Drug Application (NDA): 088389
✉ Email this page to a colleague
The generic ingredient in LIGNOSPAN FORTE is epinephrine bitartrate; lidocaine hydrochloride. There are twenty-one drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the epinephrine bitartrate; lidocaine hydrochloride profile page.
Summary for 088389
Tradename: | LIGNOSPAN FORTE |
Applicant: | Deproco |
Ingredient: | epinephrine bitartrate; lidocaine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 088389
Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
Physiological Effect | Local Anesthesia |
Suppliers and Packaging for NDA: 088389
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LIGNOSPAN FORTE | epinephrine bitartrate; lidocaine hydrochloride | INJECTABLE;INJECTION | 088389 | ANDA | Septodont, Inc. | 0362-0262 | 0362-0262-05 | 50 CARTRIDGE in 1 CARTON (0362-0262-05) / 1.7 mL in 1 CARTRIDGE |
LIGNOSPAN FORTE | epinephrine bitartrate; lidocaine hydrochloride | INJECTABLE;INJECTION | 088389 | ANDA | Septodont, Inc. | 0362-1096 | 0362-1096-70 | 5 BLISTER PACK in 1 CARTON (0362-1096-70) / 10 CARTRIDGE in 1 BLISTER PACK / 1.7 mL in 1 CARTRIDGE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 0.02MG BASE/ML;2% | ||||
Approval Date: | Jan 22, 1985 | TE: | RLD: | Yes |
Complete Access Available with Subscription